We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Role of Histamine H<sub>3</sub> and H<sub>4</sub> Receptors in Mechanical Hyperalgesia following Peripheral Nerve Injury.
- Authors
Smith, Fiona M.; Haskelberg, Hila; Tracey, David J.; Moalem-Taylor, Gila
- Abstract
Objective: Histamine is a chemical mediator that acts at four known types of histamine receptors and has been widely implicated in the development of nociception and neuropathic pain. Blocking histamine H1 and H2 receptors has been shown to reduce hyperalgesia following nerve injury, but the role of histamine H3 and H4 receptors in neuropathic pain has not been studied. Here, we used blockers of histamine H3 and H4 receptors to assess their effects on neuropathic pain behavior and mast cell numbers following peripheral nerve injury. In addition, we assessed the effect of activating H4 receptors on neuropathic pain behavior. Methods: Rats were subjected to a partial ligation of the sciatic nerve, a model of neuropathic pain, and were treated either systemically or locally (hindpaw) with the H3/H4 receptor inverse agonist thioperamide, the specific H4 receptor antagonist JNJ 7777120, or the H4 receptor agonist VUF 8430. Measurements of mechanical hyperalgesia were carried out by Randall-Selitto test for 1–3 weeks, and sciatic nerve tissues were analyzed for numbers of intact mast cells by histology at 9 h after surgery. Results: Rats treated with thioperamide or JNJ 7777120 showed significantly enhanced mechanical hyperalgesia after partial ligation of the sciatic nerve. The number of intact mast cells in the injured nerve of these rats was higher than in control rats suggesting reduced mast cell degranulation, but was still significantly lower than in intact nerves. Rats treated with VUF 8430 showed significantly reduced mechanical hyperalgesia. Conclusion: We propose that the increase in mechanical hyperalgesia produced by thioperamide and JNJ 7777120 and the decrease in mechanical hyperalgesia produced by VUF 8430 may represent a direct effect of these agents on mechanospecific primary afferents, or an indirect effect of these agents via injury-induced inflammation. Copyright © 2008 S. Karger AG, Basel
- Publication
Neuroimmunomodulation, 2008, Vol 14, Issue 6, p317
- ISSN
1021-7401
- Publication type
Article
- DOI
10.1159/000125048